These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

633 related items for PubMed ID: 29558000

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Adult-onset eculizumab-resistant hemolytic uremic syndrome associated with cobalamin C deficiency.
    Cornec-Le Gall E, Delmas Y, De Parscau L, Doucet L, Ogier H, Benoist JF, Fremeaux-Bacchi V, Le Meur Y.
    Am J Kidney Dis; 2014 Jan; 63(1):119-23. PubMed ID: 24210589
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report.
    Kourouklaris A, Ioannou K, Athanasiou I, Panagidou A, Demetriou K, Zavros M.
    J Med Case Rep; 2014 Sep 14; 8():307. PubMed ID: 25219386
    [Abstract] [Full Text] [Related]

  • 7. Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome.
    Greenbaum LA, Fila M, Ardissino G, Al-Akash SI, Evans J, Henning P, Lieberman KV, Maringhini S, Pape L, Rees L, van de Kar NC, Vande Walle J, Ogawa M, Bedrosian CL, Licht C.
    Kidney Int; 2016 Mar 14; 89(3):701-11. PubMed ID: 26880462
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report.
    Sengul Samanci N, Ayer M, Ergen A, Ozturk S.
    Transfus Apher Sci; 2015 Jun 14; 52(3):314-6. PubMed ID: 25634788
    [Abstract] [Full Text] [Related]

  • 10. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
    Krishnappa V, Gupta M, Elrifai M, Moftakhar B, Ensley MJ, Vachharajani TJ, Sethi SK, Raina R.
    Ther Apher Dial; 2018 Apr 14; 22(2):178-188. PubMed ID: 29250893
    [Abstract] [Full Text] [Related]

  • 11. Neonatal atypical hemolytic uremic syndrome due to methylmalonic aciduria and homocystinuria.
    Menni F, Testa S, Guez S, Chiarelli G, Alberti L, Esposito S.
    Pediatr Nephrol; 2012 Aug 14; 27(8):1401-5. PubMed ID: 22447314
    [Abstract] [Full Text] [Related]

  • 12. Atypical hemolytic uremic syndrome: a case report.
    Basnayake BMDB, Wazil AWM, Nanayakkara N, Samarakoon SMDK, Senavirathne EMSK, Thangarajah BUEWDR, Karunasena N, Mahanama RMBSS.
    J Med Case Rep; 2020 Jan 13; 14(1):11. PubMed ID: 31928535
    [Abstract] [Full Text] [Related]

  • 13. Neonatal atypical hemolytic uremic syndrome from a factor H mutation treated with eculizumab.
    Sharma S, Pradhan M, Meyers KE, Le Palma K, Laskin BL.
    Clin Nephrol; 2015 Sep 13; 84(3):181-5. PubMed ID: 25816809
    [Abstract] [Full Text] [Related]

  • 14. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.
    Tran H, Chaudhuri A, Concepcion W, Grimm PC.
    Pediatr Nephrol; 2014 Mar 13; 29(3):477-80. PubMed ID: 24221349
    [Abstract] [Full Text] [Related]

  • 15. Management of hemolytic uremic syndrome.
    Loirat C, Saland J, Bitzan M.
    Presse Med; 2012 Mar 13; 41(3 Pt 2):e115-35. PubMed ID: 22284541
    [Abstract] [Full Text] [Related]

  • 16. Renal recovery with eculizumab in atypical hemolytic uremic syndrome following prolonged dialysis.
    Povey H, Vundru R, Junglee N, Jibani M.
    Clin Nephrol; 2014 Nov 13; 82(5):326-31. PubMed ID: 23557793
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAλ Antibody.
    Rigothier C, Delmas Y, Roumenina LT, Contin-Bordes C, Lepreux S, Bridoux F, Goujon JM, Bachelet T, Touchard G, Frémeaux-Bacchi V, Combe C.
    Am J Kidney Dis; 2015 Aug 13; 66(2):331-6. PubMed ID: 26015278
    [Abstract] [Full Text] [Related]

  • 19. Atypical HUS due to factor H antibodies in an adult patient successfully treated with eculizumab.
    Green H, Harari E, Davidovits M, Blickstein D, Grossman A, Gafter U, Gafter-Gvili A.
    Ren Fail; 2014 Aug 13; 36(7):1119-21. PubMed ID: 24828571
    [Abstract] [Full Text] [Related]

  • 20. An international consensus approach to the management of atypical hemolytic uremic syndrome in children.
    Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, Coppo R, Emma F, Johnson S, Karpman D, Landau D, Langman CB, Lapeyraque AL, Licht C, Nester C, Pecoraro C, Riedl M, van de Kar NC, Van de Walle J, Vivarelli M, Frémeaux-Bacchi V, HUS International.
    Pediatr Nephrol; 2016 Jan 13; 31(1):15-39. PubMed ID: 25859752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.